Jeil Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Jeil Pharmaceutical Co. Ltd.
DFA Emerging Markets Small Cap Series
12,609
0.28%
2,683
0%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
8,061
0.19%
932
0%
04/30/2018
SPDR S&P International Small Cap ETF
1,467
0.03%
0
0%
09/06/2018
806
0.02%
438
0.01%
04/30/2018
John Hancock II - Emerging Markets Fund
684
0.02%
684
0%
04/30/2018
SPDR S&P World (ex-US) ETF
281
0.01%
0
0%
09/06/2018
Vanguard Total International Stock Index Fund
4
0%
0
0%
07/31/2018
Government Pension Fund - Global (The)
0
0%
-7,059
0%
12/31/2017
Samsung KODEX Leverage ETF
0
0%
-1,147
0%
04/30/2018
| Address |
343 Sapyeong-daero
Seoul SL 06543
Korea, Republic Of
|
|
Employees
|
- |
| Website |
- |
| Updated |
07/08/2019 |
| Jeil Pharma Holdings, Inc. engages in the manufacture and sale of pharmaceutical products. Its products include active pharmaceutical ingredients and finished dosage forms. The active pharmaceutical ingredients provide medicines for antibiotic, oncology, cardiovascular, gastrointestinal, neuropsychiatry, urology, endocrinology, respiratory, antiviral, and musculoskeletal. |
